Physician profile
Roshin Thomas
NPI 1619300571
$18,110.29
in general payments reported to CMS, 2019-2025
11 companies · $805 in 2025
The $805 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $245 · 2021: $6,032 · 2022: $6,192 · 2023: $4,443 · 2024: $260 · 2025: $805.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,600 · Food and Beverage: $1,383 · Travel and Lodging: $510 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,600.00 |
| Food and Beverage | $1,382.73 |
| Travel and Lodging | $509.59 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17,277.98 | 2020-2025 | Davinci Xi, Da Vinci Surgical System |
| Ethicon US, LLC | $430.13 | 2019-2025 | Echelon Flex, Enseal, Harmonic |
| Lemaitre Vascular, INC. | $88.01 | 2022-2025 | Artegraft Vascular Graft |
| Solventum Corporation | $82.57 | 2024-2025 | Activ.A.C., V.A.C. Veraflo Cleanse Choice, Prevena |
| Medtronic, INC. | $63.42 | 2023-2024 | Signia, Progrip |
| Lifenet Health | $45.14 | 2025 | Theragenesis Wound Matrix |
| Convatec INC. | $44.33 | 2025 | |
| Davol INC. | $21.88 | 2021 | |
| Hartmann USA, INC. | $20.88 | 2024 | Zetuvit Plus 10x10 P10 |
| Pacira Pharmaceuticals Incorporated | $20.63 | 2024 | Exparel |
| Smith+Nephew, INC. | $15.32 | 2023 | Stravix Pl, Oasis, Grafix Pl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roshin Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.